Literature DB >> 22145475

A novel homozygous HESX1 mutation causes panhypopituitarism without midline defects and optic nerve anomalies.

Burak Durmaz1, Ozgur Cogulu, Ceyhun Dizdarer, Heike Stobbe, Roland Pfaeffle, Ferda Ozkinay.   

Abstract

OBJECTIVE: There are many genes reported to have been associated with combined pituitary hormone deficiencies, but mutations in HESX1 strongly correlate with septo-optic dysplasia. Our aim was to determine the cause of panhypopituitarism in our patient. PATIENTS AND METHODS: We studied an 8-month-old child having panhypopituitarism. The coding exons of PIT1, PROP1, LHX3, and HESX1 genes were amplified. Direct sequencing was done after denaturing HLPC.
RESULTS: We identified a novel homozygous mutation (R160H) within the homeodomain of HESX1, which, to our knowledge, is the first to be described in humans. Neuroimaging studies revealed anterior pituitary aplasia, a normal posterior pituitary gland, and a thin pituitary stalk but no midline abnormalities. Optic nerve studies showed no pathology. This mutation is also carried in the parents of the affected child in a heterozygous pattern, suggesting an autosomal recessive inheritance.
CONCLUSION: These data demonstrate that homozygous HESX1 mutation causing an R160H substitution can result in panhypopituitarism without midline defects.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22145475     DOI: 10.1515/jpem.2011.162

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  5 in total

1.  HESX1 mutations in patients with congenital hypopituitarism: variable phenotypes with the same genotype.

Authors:  Qing Fang; Anna Flavia Figueredo Benedetti; Qianyi Ma; Louise Gregory; Jun Z Li; Mehul Dattani; Abdollah Sadeghi-Nejad; Ivo J P Arnhold; Berenice Bilharinho Mendonca; Sally A Camper; Luciani R Carvalho
Journal:  Clin Endocrinol (Oxf)       Date:  2016-04-28       Impact factor: 3.478

2.  Molecular analysis of PROP1, POU1F1, LHX3, and HESX1 in Turkish patients with combined pituitary hormone deficiency: a multicenter study.

Authors:  Firdevs Baş; Z Oya Uyguner; Feyza Darendeliler; Zehra Aycan; Ergun Çetinkaya; Merih Berberoğlu; Zeynep Şiklar; Gönül Öcal; Şükran Darcan; Damla Gökşen; Ali Kemal Topaloğlu; Bilgin Yüksel; Mehmet Nuri Özbek; Oya Ercan; Olcay Evliyaoğlu; Semra Çetinkaya; Yaşar Şen; Emre Atabek; Güven Toksoy; Banu Küçükemre Aydin; Rüveyde Bundak
Journal:  Endocrine       Date:  2014-12-11       Impact factor: 3.633

Review 3.  Genetics of Combined Pituitary Hormone Deficiency: Roadmap into the Genome Era.

Authors:  Qing Fang; Akima S George; Michelle L Brinkmeier; Amanda H Mortensen; Peter Gergics; Leonard Y M Cheung; Alexandre Z Daly; Adnan Ajmal; María Ines Pérez Millán; A Bilge Ozel; Jacob O Kitzman; Ryan E Mills; Jun Z Li; Sally A Camper
Journal:  Endocr Rev       Date:  2016-11-09       Impact factor: 19.871

4.  Identification of HESX1 mutations in Kallmann syndrome.

Authors:  Kayce Newbern; Nithya Natrajan; Hyung-Goo Kim; Lynn P Chorich; Lisa M Halvorson; Richard S Cameron; Lawrence C Layman
Journal:  Fertil Steril       Date:  2013-03-01       Impact factor: 7.329

Review 5.  The Genetic Backdrop of Hypogonadotropic Hypogonadism.

Authors:  Anna Szeliga; Michal Kunicki; Marzena Maciejewska-Jeske; Natalia Rzewuska; Anna Kostrzak; Blazej Meczekalski; Gregory Bala; Roman Smolarczyk; Eli Y Adashi
Journal:  Int J Mol Sci       Date:  2021-12-08       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.